InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Cullinan Therapeutics, Inc.

CGEM Clue Score48
United States Fiscal year ends December CIK 0001789972 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

25
Insider
Date
Role
Action
Shares
Price
Amount
Lynx1 Capital Management LP
28 Oct 2025
10% owner
Buy indirect
165,667
$8.40
$1.39M
Lynx1 Capital Management LP
17 Oct 2025
10% owner
Buy indirect
32,217
$7.84
$252.57K
Lynx1 Capital Management LP
16 Oct 2025
10% owner
Buy indirect
150,000
$8.86
$1.33M
Lynx1 Capital Management LP
15 Oct 2025
10% owner
Buy indirect
51,500
$7.94
$409.05K
Lynx1 Capital Management LP
14 Oct 2025
10% owner
Buy indirect
15,032
$7.59
$114.05K
Lynx1 Capital Management LP
10 Oct 2025
10% owner
Buy indirect
277,298
$7.36
$2.04M
Lynx1 Capital Management LP
9 Oct 2025
10% owner
Buy indirect
626,043
$6.70
$4.19M
Lynx1 Capital Management LP
8 Oct 2025
10% owner
Buy indirect
556,300
$6.46
$3.59M
Nadim Ahmed
6 Jun 2022
President and CEO
Buy
8,090
$12.40
$100.32K
Bvf Partners L P/Il
1 Jun 2022
10% owner
Buy
44,746
$11.00
$492.18K
Bvf Partners L P/Il
1 Jun 2022
10% owner
Buy
301,009
$11.00
$3.31M
Bvf Partners L P/Il
1 Jun 2022
10% owner
Buy
405,641
$11.00
$4.46M
Bvf Partners L P/Il
13 May 2022
10% owner
Buy
17,744
$9.14
$162.09K
Bvf Partners L P/Il
13 May 2022
10% owner
Buy
38,558
$9.14
$352.23K
Bvf Partners L P/Il
13 May 2022
10% owner
Buy
53,598
$9.14
$489.62K
Bvf Partners L P/Il
12 May 2022
10% owner
Buy
457,001
$9.06
$4.14M
Bvf Partners L P/Il
12 May 2022
10% owner
Buy
542,999
$9.06
$4.92M
Bvf Partners L P/Il
1 Apr 2022
10% owner
Buy
9,402
$10.75
$101.07K
Bvf Partners L P/Il
1 Apr 2022
10% owner
Buy
266,598
$10.75
$2.87M
Jeffrey Trigilio
12 Jan 2021
Chief Financial Officer
Buy
2,250
$21.00
$47.25K
Owen Hughes
12 Jan 2021
President and CEO
Buy
2,500
$21.00
$52.50K
Morana Jovan-Embiricos
12 Jan 2021
Director
Buy indirect
104,762
$21.00
$2.20M
Morana Jovan-Embiricos
12 Jan 2021
Director
Buy indirect
95,238
$21.00
$2.00M
Ansbert Gadicke
12 Jan 2021
Director
Buy indirect
300,000
$21.00
$6.30M
UBS Oncology Impact Fund L.P.
12 Jan 2021
10% owner
Buy
300,000
$21.00
$6.30M
Show all 213 transactions →

What was left out

Form 4 filings counted 220
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 34
Sales at will 139
Transactions with no price 0
Shares from compensation/vesting 31,067,955
Sales filed before the plan box existed 81
History held since 11 Jan 2021